VERTEX PHARMACEUTICALS INC / MA (VRTX) Gross margin 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
86.2%FY2025 · since FY2016: 87.6% → 86.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 86.2% | +0.1 pp |
| FY2024 | 86.1% | -1.1 pp |
| FY2023 | 87.2% | -0.7 pp |
| FY2022 | 87.9% | -0.2 pp |
| FY2021 | 88.1% | -0.1 pp |
| FY2020 | 88.1% | +1.3 pp |
| FY2019 | 86.8% | +0.3 pp |
| FY2018 | 86.6% | -2.4 pp |
| FY2017 | 88.9% | +1.3 pp |
| FY2016 | 87.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice